We are thrilled to FINALLY announce our partnership with Allergan – one of the world’s top 20 pharmaceutical companies (by revenue). We will be supplying our advanced CoQ10 antioxidant (MitoQ) for use in the new LUMIVIVE® product line, marketed under the SkinMedica® brand.
It will be the first time that MitoQ has agreed to supply our patented ingredient to a third-party product range, so we had to make sure we were handing our baby over to someone who would create a product to the same high standard that we hold ourselves to. For nearly 20 years SkinMedica® innovations have been changing the face of skincare and have been a leading choice of physicians and their patients. We believe in the premium quality and science behind their products, so it was a natural choice for us.
The LUMIVIVE® System from SkinMedica® is designed with two distinct formulas, and LUMIVIVE® Night Revitalize Repair Complex, which contains the MitoQ ingredient, works to recharge the skin’s essential repair process at night.
“Healthy mitochondria are essential to maintaining youthful skin, sustained energy, focus and overall wellness. MitoQ’s proprietary technology has the ability to work directly inside the mitochondria to re-energize the body from the inside out,” said Greg MacPherson, CEO of MitoQ. “SkinMedica® is a brand built on science, with scientifically-proven ingredients in their products, and we are thrilled that they believe in the effectiveness of MitoQ and have included it in their new product line, the LUMIVIVE® System.”
MitoQ is excited to be recognized by a pharmaceutical company who has such a large portfolio and reach, and to have the opportunity to increase awareness of the importance of mitochondrial health and further strengthen our brand identity in the skincare market.